Literature DB >> 12507890

Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.

Anna Taranta1, Silvia Migliaccio, Irene Recchia, Maurizio Caniglia, Matteo Luciani, Giulio De Rossi, Carlo Dionisi-Vici, Rita M Pinto, Paola Francalanci, Renata Boldrini, Edoardo Lanino, Giorgio Dini, Giuseppe Morreale, Stuart H Ralston, Anna Villa, Paolo Vezzoni, Domenico Del Principe, Flaminia Cassiani, Giuseppe Palumbo, Anna Teti.   

Abstract

Autosomal-recessive osteopetrosis is a severe genetic disease caused by osteoclast failure. Approximately 50% of the patients harbor mutations of the ATP6i gene, encoding for the osteoclast-specific a3 subunit of V-ATPase. We found inactivating ATP6i mutations in four patients, and three of these were novel. Patients shared macrocephaly, growth retardation and optic nerve alteration, osteosclerotic and endobone patterns, and high alkaline phosphatase and parathyroid hormone levels. Bone biopsies revealed primary spongiosa lined with active osteoblasts and high numbers of tartrate-resistant acid phosphatase (TRAP)-positive, a3 subunit-negative, morphologically unremarkable osteoclasts, some of which located in shallow Howship lacunae. Scarce hematopoietic cells and abundant fibrous tissue containing TRAP-positive putative osteoclast precursors were noted. In vitro osteoclasts were a3-negative, morphologically normal, with prominent clear zones and actin rings, and TRAP activity more elevated than in control patients. Podosomes, alphaVbeta3 receptor, c-Src, and PYK2 were unremarkable. Consistent with the finding in the bone biopsies, these cells excavated pits faintly stained with toluidine blue, indicating inefficient bone resorption. Bone marrow transplantation was successful in all patients, and posttransplant osteoclasts showed rescue of a3 subunit immunoreactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507890      PMCID: PMC1851135          DOI: 10.1016/S0002-9440(10)63798-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Interaction between vacuolar H(+)-ATPase and microfilaments during osteoclast activation.

Authors:  B S Lee; S L Gluck; L S Holliday
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

2.  The amino-terminal domain of the B subunit of vacuolar H+-ATPase contains a filamentous actin binding site.

Authors:  L S Holliday; M Lu; B S Lee; R D Nelson; S Solivan; L Zhang; S L Gluck
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

Review 3.  Biochemical markers of bone formation.

Authors:  C M Gundberg
Journal:  Clin Lab Med       Date:  2000-09       Impact factor: 1.935

Review 4.  The structure of the vacuolar ATPase in Neurospora crassa.

Authors:  E Margolles-Clark; K Tenney; E J Bowman; B J Bowman
Journal:  J Bioenerg Biomembr       Date:  1999-02       Impact factor: 2.945

5.  Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.

Authors:  A M Flanagan; U Sarma; C G Steward; A Vellodi; M A Horton
Journal:  J Bone Miner Res       Date:  2000-02       Impact factor: 6.741

6.  Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.

Authors:  U Kornak; A Schulz; W Friedrich; S Uhlhaas; B Kremens; T Voit; C Hasan; U Bode; T J Jentsch; C Kubisch
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

Review 7.  The cell biology of osteoclast function.

Authors:  H K Väänänen; H Zhao; M Mulari; J M Halleen
Journal:  J Cell Sci       Date:  2000-02       Impact factor: 5.285

8.  Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures.

Authors:  A Teti; S Migliaccio; A Taranta; S Bernardini; G De Rossi; M Luciani; M Iacobini; L De Felice; R Boldrini; C Bosman; A Corsi; P Bianco
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

9.  Decreased c-Src expression enhances osteoblast differentiation and bone formation.

Authors:  M Marzia; N A Sims; S Voit; S Migliaccio; A Taranta; S Bernardini; T Faraggiana; T Yoneda; G R Mundy; B F Boyce; R Baron; A Teti
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.

Authors:  A Frattini; P J Orchard; C Sobacchi; S Giliani; M Abinun; J P Mattsson; D J Keeling; A K Andersson; P Wallbrandt; L Zecca; L D Notarangelo; P Vezzoni; A Villa
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

View more
  26 in total

1.  Osteoclasts and hematopoiesis.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2012-03-28

Review 2.  The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.

Authors:  J Keller; T Schinke
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

3.  The virulence gene and clinical phenotypes of osteopetrosis in the Chinese population: six novel mutations of the CLCN7 gene in twelve osteopetrosis families.

Authors:  Chun Wang; Hao Zhang; Jin-Wei He; Jie-Mei Gu; Wei-Wei Hu; Yun-Qiu Hu; Miao Li; Yu-Juan Liu; Wen-Zhen Fu; Hua Yue; Yao-Hua Ke; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2011-09-28       Impact factor: 2.626

4.  Identification of inhibitors of vacuolar proton-translocating ATPase pumps in yeast by high-throughput screening flow cytometry.

Authors:  Rebecca M Johnson; Chris Allen; Sandra D Melman; Anna Waller; Susan M Young; Larry A Sklar; Karlett J Parra
Journal:  Anal Biochem       Date:  2009-12-14       Impact factor: 3.365

5.  Impaired gastric acidification negatively affects calcium homeostasis and bone mass.

Authors:  Thorsten Schinke; Arndt F Schilling; Anke Baranowsky; Sebastian Seitz; Robert P Marshall; Tilman Linn; Michael Blaeker; Antje K Huebner; Ansgar Schulz; Ronald Simon; Matthias Gebauer; Matthias Priemel; Uwe Kornak; Sandra Perkovic; Florian Barvencik; F Timo Beil; Andrea Del Fattore; Annalisa Frattini; Thomas Streichert; Klaus Pueschel; Anna Villa; Klaus-Michael Debatin; Johannes M Rueger; Anna Teti; Jozef Zustin; Guido Sauter; Michael Amling
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 6.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

7.  Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse.

Authors:  Barbara Tondelli; Harry C Blair; Matteo Guerrini; Kenneth D Patrene; Barbara Cassani; Paolo Vezzoni; Franco Lucchini
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

8.  Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.

Authors:  Anita V Neutzsky-Wulff; Mette G Sørensen; Dino Kocijancic; Diana J Leeming; Morten H Dziegiel; Morten A Karsdal; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-01       Impact factor: 2.362

9.  Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.

Authors:  Mette G Sørensen; Morten A Karsdal; Morten H Dziegiel; Jean A Boutin; Olivier Nosjean; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

10.  Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.

Authors:  Kim Henriksen; Jeppe Gram; Sophie Schaller; Bjarne H Dahl; Morten H Dziegiel; Jens Bollerslev; Morten A Karsdal
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.